Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENTA Enanta Pharmaceuticals Inc.

交易中 09-09 15:20:33 EDT

13.18

-0.32

-2.41%

最高13.51	最低13.12	成交量12.49万
今开13.50	昨收13.50	日振幅2.89%
总市值3.82亿	流通市值2.97亿	总股本2,902万
成交额165.82万	换手率0.55%	流通股本2,251万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENTA","market":"US","secType":"STK","nameCN":"Enanta Pharmaceuticals Inc.","latestPrice":13.175,"timestamp":1788981628982,"preClose":13.5,"halted":0,"volume":124855,"delay":0,"changeRate":-0.024074074074074022,"floatShares":22513000,"shares":29018522,"eps":-2.341617,"marketStatus":"交易中","change":-0.325,"latestTime":"09-09 15:20:33 EDT","open":13.5,"high":13.51,"low":13.12,"amount":1658182.898995,"amplitude":0.028889,"askPrice":13.19,"askSize":181,"bidPrice":13.16,"bidSize":201,"shortable":3,"etf":0,"ttmEps":-2.341617,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1788984000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1363838400000,"exchange":"NASDAQ","adjPreClose":13.5,"postHourTrading":{"tag":"盘后","latestPrice":13.5,"preClose":13.5,"latestTime":"19:30 EDT","volume":5636,"amount":76086,"timestamp":1788910208755,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.630538,"impliedVol":0.5227,"impliedVolPercentile":0.3984},"requestUrl":"/m/hq/s/ENTA","defaultTab":"news","newsList":[{"id":"1188827022","title":"Enanta Pharmaceuticals第三季度营收1435.9万美元，不及市场预期1680万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188827022","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188827022?lang=zh_cn&edition=full","pubTime":"2026-08-11 04:17","pubTimestamp":1786393060,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals（股票代码：ENTA）公布第三季度财报，数据显示该公司净亏损达1950.1万美元。相比之下，市场此前普遍预期其营收为1680万美元，而实际营收仅为1435.9万美元，未达预期目标。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127276329","title":"联邦巡回上诉法院于2026年6月23日裁定Enanta Pharmaceuticals '953专利权利要求无效 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1127276329","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127276329?lang=zh_cn&edition=full","pubTime":"2026-06-24 05:30","pubTimestamp":1782250215,"startTime":"0","endTime":"0","summary":"根据一份提交至美国证券交易委员会的文件，联邦巡回上诉法院已于2026年6月23日作出裁决，维持了Enanta Pharmaceuticals公司一项关键专利权利要求无效的判决。这一决定涉及该公司的'953专利，对Enanta Pharmaceuticals的知识产权布局构成直接影响。公司依照规定，通过正式文件向监管机构及投资者披露了这一重大法律进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112364953","title":"Enanta Pharmaceuticals合作伙伴艾伯维获欧盟批准，Maviret®用于治疗急性丙型肝炎病毒感染者","url":"https://stock-news.laohu8.com/highlight/detail?id=1112364953","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112364953?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:11","pubTimestamp":1782205869,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals的合作伙伴艾伯维公司，其药物Maviret®（格卡瑞韦/哌仑他韦）已获得欧盟委员会的批准，可用于治疗急性丙型肝炎病毒感染者。这一进展标志着该药物应用范围的进一步扩大，为相关患者群体提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197752103","title":"Enanta Pharmaceuticals：针对高风险成人RSV的注册性2B/3期试验将于2026年第四季度启动；2B期顶线数据预计2027年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1197752103","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197752103?lang=zh_cn&edition=full","pubTime":"2026-06-18 19:02","pubTimestamp":1781780538,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals Inc. 宣布，其针对高风险成人呼吸道合胞病毒的注册性2B/3期临床试验计划于2026年第四季度启动。与此同时，关键的2B期临床试验的顶线数据预计将在2027年获得。这项试验的启动标志着该公司在RSV治疗领域研发进程的重要一步。注册性试验旨在为未来的监管申请提供关键支持数据。针对高风险成人群体，如老年人或存在基础疾病的患者，有效的RSV治疗方案存在显著的未满足医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167163887","title":"Enanta Pharmaceuticals宣布其呼吸道合胞病毒治疗药物Zelicapavir临床开发项目取得进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1167163887","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167163887?lang=zh_cn&edition=full","pubTime":"2026-06-18 19:01","pubTimestamp":1781780477,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals宣布，其针对呼吸道合胞病毒感染的治疗药物Zelicapavir的临床开发项目已取得重要进展。这一进展标志着该公司在抗病毒药物研发领域迈出了关键一步，旨在应对目前临床需求尚未被完全满足的呼吸道合胞病毒感染。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117302370","title":"Enanta Pharmaceuticals 有望于2026年下半年提交EPS-3903新药临床试验申请并选定Mrgprx2候选药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1117302370","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117302370?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:03","pubTimestamp":1778529806,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals Inc. 宣布，公司正按计划推进，目标在2026年下半年提交其候选药物EPS-3903的新药临床试验申请，并完成针对Mrgprx2靶点的候选药物的选定工作。这两项进展标志着该公司在相关治疗领域的研发管线取得了重要阶段性成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123899924","title":"Enanta Pharmaceuticals启动EDP-978一期临床试验 首例受试者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1123899924","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123899924?lang=zh_cn&edition=full","pubTime":"2026-04-13 19:03","pubTimestamp":1776078203,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals宣布，其研发的口服每日一次KIT抑制剂EDP-978已在一期临床试验中完成首例受试者给药。该药物目前正针对荨麻疹治疗进行开发，标志着公司在该疾病领域取得重要研究进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518277610","title":"Enanta Pharmaceuticals, Inc.盘中异动 急速下跌5.12%报6.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518277610?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:18","pubTimestamp":1741623535,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时18分，Enanta Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.12%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001855a26a6261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001855a26a6261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516668835","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516668835?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:54","pubTimestamp":1741031659,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时54分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.01%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304035420abe68c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304035420abe68c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514243320","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.71%报7.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514243320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514243320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753050,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.71%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223050a25800a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223050a25800a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514686416","title":"Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514686416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514686416?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:01","pubTimestamp":1740600098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时01分，Enanta Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.06%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227040138963189d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227040138963189d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514718617","title":"Enanta Pharmaceuticals, Inc.盘中异动 临近午盘急速上涨5.48%报8.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514718617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514718617?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:47","pubTimestamp":1740415634,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时47分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.48%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225004715a2523346&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225004715a2523346&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512488073","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512488073?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:46","pubTimestamp":1739976378,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时46分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.07%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224618abd501ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224618abd501ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512519404","title":"Enanta Pharmaceuticals, Inc.盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512519404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512519404?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:31","pubTimestamp":1739910700,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时31分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.04%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190431409627d04b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190431409627d04b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511617854","title":"Enanta Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌5.07%报7.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511617854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511617854?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:49","pubTimestamp":1739566144,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时49分，Enanta Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.07%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215044904abcf55fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215044904abcf55fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511296525","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511296525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511296525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.29%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223113abcdb1ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223113abcdb1ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510438089","title":"Enanta Pharmaceuticals, Inc.股价飙升10.00% 市值涨1149.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510438089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510438089?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:32","pubTimestamp":1739284326,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时32分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速上涨10.00%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223206abcb0626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223206abcb0626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135072646","title":"Enanta Pharma第一季度每股收益$(1.05)好于预期$(1.35)，销售额$1696万低于预期$1725万","url":"https://stock-news.laohu8.com/highlight/detail?id=1135072646","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135072646?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:17","pubTimestamp":1739222274,"startTime":"0","endTime":"0","summary":"Enanta Pharma 报告季度每股亏损$，好于分析师共识预期的$，超出22.22%。与去年同期每股亏损$相比，这是一个33.54%的增幅。公司报告季度销售额为1696万美元，低于分析师共识预期的1725万美元，差距为1.68%。以上内容来自Benzinga Earnings专栏，原文如下：Enanta Pharma  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 22.22 percent. This is a 33.54 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $16.96 million which missed the analyst consensus estimate of $17.25 million by 1.68 percent.  Thi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Enanta Pharma第一季度每股收益$(1.05)好于预期$(1.35)，销售额$1696万低于预期$1725万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504019251","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504019251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504019251?lang=zh_cn&edition=full","pubTime":"2025-01-18 01:33","pubTimestamp":1737135234,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日01时33分，Enanta Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.15%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118013354abaed958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118013354abaed958&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502860494","title":"Enanta Pharmaceuticals, Inc.盘中异动 急速跳水5.03%报4.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502860494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502860494?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:06","pubTimestamp":1736521603,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时06分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.03%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102306439861f1a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102306439861f1a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.enanta.com","stockEarnings":[{"period":"1week","weight":-0.0007},{"period":"1month","weight":-0.0196},{"period":"3month","weight":0.1538},{"period":"6month","weight":0.0067},{"period":"1year","weight":0.5152},{"period":"ytd","weight":-0.1439}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.0094},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.15},{"period":"1year","weight":0.1805},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Enanta Pharmaceuticals, Inc.于1995年根据特拉华州法律注册成立。该公司是一家生物技术公司，利用强大的、化学驱动的方法和药物发现能力来发现和开发用于病毒学和免疫学适应症的小分子药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.034398},{"month":2,"riseRate":0.615385,"avgChangeRate":0.072592},{"month":3,"riseRate":0.538462,"avgChangeRate":-0.025585},{"month":4,"riseRate":0.5,"avgChangeRate":-0.004464},{"month":5,"riseRate":0.357143,"avgChangeRate":-0.052374},{"month":6,"riseRate":0.571429,"avgChangeRate":0.052182},{"month":7,"riseRate":0.5,"avgChangeRate":-0.016041},{"month":8,"riseRate":0.571429,"avgChangeRate":0.020882},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.006253},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.020104},{"month":11,"riseRate":0.692308,"avgChangeRate":0.077463},{"month":12,"riseRate":0.692308,"avgChangeRate":-0.00172}],"exchange":"NASDAQ","name":"Enanta Pharmaceuticals Inc.","nameEN":"Enanta Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Enanta Pharmaceuticals Inc.(ENTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Enanta Pharmaceuticals Inc.,ENTA,Enanta Pharmaceuticals Inc.股票,Enanta Pharmaceuticals Inc.股票老虎,Enanta Pharmaceuticals Inc.股票老虎国际,Enanta Pharmaceuticals Inc.行情,Enanta Pharmaceuticals Inc.股票行情,Enanta Pharmaceuticals Inc.股价,Enanta Pharmaceuticals Inc.股市,Enanta Pharmaceuticals Inc.股票价格,Enanta Pharmaceuticals Inc.股票交易,Enanta Pharmaceuticals Inc.股票购买,Enanta Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Enanta Pharmaceuticals Inc.(ENTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}